Company Guangdong Hybribio Biotech Co.,Ltd.

Equities

300639

CNE100002N51

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Guangdong Hybribio Biotech Co.,Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
6.2 ^CNY	+2.31%		+1.47%	-33.62%

Apr. 26	Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 23	Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Guangdong Hybribio Biotech Co Ltd is a company mainly engaged in production and sales of vitro diagnostic reagents. The Company operates two segments. The In Vitro Diagnostic Reagents and Supporting Equipment segment operates the research, development and production of nucleic acid detection reagents and supporting equipment, such as cervical cancer detection series products, deafness susceptibility gene detection series products and reproductive health management series products. The products are used in hospital clinical testing, large-scale population screening and other areas. The Medical Testing Service segment is involved in providing medical testing services for medical institutions, and the testing programs cover genetic metabolic diseases, infectious diseases, molecular pathological testing and tumor examinations.

Number of employees: 3,339

CNY in Million	2022	Weight	2023	Weight	Delta
In Vitro Diagnostic Reagents, Supporting Instruments and Consumables 75.8 %	2,670	47.7 %	838	75.8 %	-68.63%
Medical Testing 37.8 %	4,387	78.4 %	418	37.8 %	-90.48%
Inter-segment Elimination -13.7 %	-1,460	-26.1 %	-151	-13.7 %	-89.66%

CNY in Million	2022	Weight	2023	Weight	Delta
China 93.4 %	3,931	70.2 %	1,031	93.4 %	-73.76%
Overseas 6.6 %	1,666	29.8 %	73	6.6 %	-95.61%

Managers	Title	Age	Since
Qiao Zhong Guan FOU	Founder	75	03-06-12
Qing Hui Li DFI	Director of Finance/CFO	59	13-12-31
Jian Yu Wang COO	Chief Operating Officer	63	02-12-31
Wan Jian Xu BRD	Director/Board Member	38	10-12-31
Zhi Sheng Guan BRD	Director/Board Member	40	06-12-31
Xian Yuan IRC	Investor Relations Contact	-	-
Yi Chen IRO	Public Communications Contact	45	06-12-31

Members of the board	Title	Age	Since
Wei XIong Huang CHM	Chairman	60	02-12-31
Qiao Zhong Guan FOU	Founder	75	03-06-12
Xiao Yan Yang BRD	Director/Board Member	61	02-12-31
Jian Yu Wang COO	Chief Operating Officer	63	02-12-31
Zhi Sheng Guan BRD	Director/Board Member	40	06-12-31
Guan Ping Hong BRD	Director/Board Member	62	16-09-06
You Gen Tang BRD	Director/Board Member	62	16-09-06
Wan Jian Xu BRD	Director/Board Member	38	10-12-31
Fu Xiong Xu BRD	Director/Board Member	72	19-09-01
Rui Jun Ma CHM	Chairman	68	18-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	661,706,518	329,537,853 ( 49.80 %)	15,205,844 ( 2.298 %)	49.80 %

Name	Equities	%	Valuation
Guan Qiao Zhong Family 30.01 %	193,198,317	30.01 %	189 M ¥
Yunnan Zhonghezhi Management Co. Ltd. 6.237 %	40,147,565	6.237 %	39 M ¥
China Merchants Capital Investment Co. Ltd. 4.779 %	30,765,712	4.779 %	30 M ¥
Jian Hui Wang 2.274 %	14,637,483	2.274 %	14 M ¥
GUANGDONG HYBRIBIO BIOTECH CO.,LTD. 1.765 %	11,358,800	1.765 %	11 M ¥
Dan Ping Cai 1.107 %	7,128,057	1.107 %	7 M ¥
Beijing Xinweigang Technology Co. Ltd. 0.6807 %	4,381,716	0.6807 %	4 M ¥
Jian Yu Wang 0.4248 %	2,734,446	0.4248 %	3 M ¥
Wei Jian Liao 0.3958 %	2,547,600	0.3958 %	2 M ¥
University of Hong Kong 0.3141 %	2,022,150	0.3141 %	2 M ¥

Name	Equities	%	Valuation
Jian Yu Wang 72.22 %	8,203,337	72.22 %	8 M ¥
Zhi Sheng Guan 24.03 %	2,729,778	24.03 %	3 M ¥
Qing Hui Li 0.4016 %	45,614	0.4016 %	44 557 ¥

Name	Equities	%	Valuation
GUANGDONG HYBRIBIO BIOTECH CO.,LTD. 1.76%	11,358,800	1.76%	11,095,617 $

Guangdong Hybribio Biotech Co., Ltd.

D5-3-3-4 Sub-Zone Beipian High-tech Zone, Pilot Zone

521000, Chaozhou

+86 76 8285 2923

http://www.hybribio.cn

address Guangdong Hybribio Biotech Co.,Ltd.(300639)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.2

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
GUANGDONG HYBRIBIO BIOTECH CO.,LTD.	-33.62%	546M
BIOMÉRIEUX	+0.89%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
10X GENOMICS, INC.	-50.70%	3.3B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
VITROLIFE AB	-16.13%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B
MYRIAD GENETICS, INC.	-5.02%	1.64B

Diagnostic & Testing Substances